RWM
LXRX icon

Raffa Wealth Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Raffa Wealth Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-63
Closed -$1.04K – 341
2017
Q2 		$1.04K Hold
63
– – ﹤0.01% 349
2017
Q1 		$903 Hold
63
– – ﹤0.01% 339
2016
Q4 		$871 Buy
63
+9
+17% +$144 ﹤0.01% 478
2016
Q3 		$976 Hold
54
– – ﹤0.01% 428
2016
Q2 		$775 Buy
54
+8
+17% +$109 ﹤0.01% 481
2016
Q1 		$550 Buy
+46
New +$482 ﹤0.01% 648

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $27.8B AUM 39.42% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Raffa Wealth Management's LXRX Position: Q3 2017 in Review

Raffa Wealth Management sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2017, closing a stake of 63 shares — an estimated $1.04K sold.

Raffa Wealth Management first reported a position in LXRX in Q1 2016 and held it in 6 quarters. The position peaked at $1.04K in Q2 2017. 137 funds tracked by Wall St. Rank hold LXRX as of Q3 2017.

  • Raffa Wealth Management reported no remaining Lexicon Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Raffa Wealth Management sold 63 Lexicon Pharmaceuticals shares in Q3 2017, an estimated $1.04K.
  • Raffa Wealth Management first reported a position in Lexicon Pharmaceuticals in Q1 2016 and held it in 6 quarters.
  • Raffa Wealth Management's Lexicon Pharmaceuticals position peaked at $1.04K in Q2 2017.
  • 137 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2017.

Based on Raffa Wealth Management's 13F filing for Q3 2017, filed 27 Jul 2026.